Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Coeloglossum viride extract protective in models of brain ischemia

March 16, 2009

GPR3 identified as a new pharmacological target for Alzheimer's disease

March 16, 2009

Novartis presents novel GABA-A receptor ligands

March 13, 2009

Novel beta-secretase inhibitors claimed by CoMentis and Purdue Research Foundation

March 13, 2009

Neurogen presents novel heteroaryl amide analogues

March 13, 2009

Preliminary findings suggest AD-01, AD-02 vaccines are safe in Alzheimer's disease patients

March 13, 2009

Dimebolin safe, improves cognition in Huntington's disease patients

March 13, 2009

FDA approves Insmed's Iplex for ALS under IND applications

March 13, 2009

Targacept to discontinue development of TC-6499 for neuropathic pain

March 12, 2009

Medicure cleared to commence phase II Avastrem trial for tardive dyskinesia

March 12, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...